View Cart (0 items)
Renal News / Home Dialysis

Session on new home dialysis technology planned for patient meeting

September 14, 2012
/ Print / Reprints /
| Share More
/ Text Size+

Home Dialyzors United will offer an informative look at innovations in dialysis treatment, with a focus on home dialysis, at its third Meet-up and Conference, being held Oct. 7-10 in Baltimore. On Oct. 9, four companies will give presentations on new technology.

  • NxStage Medical will preview HomeView, its online iPad and iCloud-based reporting system for home dialyzors who use the company’s System One portable dialysis machine. HomeView will simplify the time-intensive process of dialyzors completing and transmitting treatment flow sheets, and thereby facilitate better patient-oversight and faster reimbursement for dialysis providers, NxStage says.
  • Quanta Fluid Solutions of Warwickshire, UK, will present an overview of SelfCare+, a small, high-flow-rate, home hemodialysis machine. SelfCare+ generates on demand bicarbonate-based dialysate using a disposable cartridge, enabling patients to dialyze at any time with minimal preparation steps.
  • Fresenius Medical Care North America will present a talk on PAK, a portable hemodialysis machine that provides regenerated dialysate using very little initial tap water and sorbent technology to continuously renew the dialysis fluid. It also features a disposable cartridge with dialysate fluid lines, bloodlines and a pre-attached hollow-fiber artificial kidney, no air-blood interface, and automated prime and rinse-back. The PAK is currently before the FDA for approval as an in-center hemodialysis machine. Clinical trials are expected in 2013 to generate data for home use indication.
  • Affymax Inc. will discuss its FDA-approved Omontys (peginesatide), injectable erythropoiesis-stimulating agent for the treatment of anemia in adult dialysis patients. Today, it is the only once-monthly ESA available to dialyzors in the United States. 

Click here for a full agenda and for registration.

You must login or register in order to post a comment.